Myocardial contractile effects of L-arginine in the human allograft

Journal of the American College of Cardiology

Volumn 29, Issue 6, 1997, Pages 1332-1338

  Paulus, Walter J ^a   Kästner, Stefanie ^b   Vanderheyden, Marc ^a   Shah, Ajay M ^c   Drexler, Helmut ^b  

^a CARDIOVASCULAR CENTER   (Belgium)

^b UNIVERSITY OF FREIBURG   (Germany)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DOBUTAMINE; NITRIC OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART TRANSPLANTATION; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

ARGININE; CORONARY ANGIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; HEART CATHETERIZATION; HEART TRANSPLANTATION; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBSTANCE P; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 0343196711     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00056-9     Document Type: Article

References (40)

1. Paulus WJ, Vantrimpont P, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Circulation. 89:1994;2070-2078.
2. Paulus WJ, Vantrimpont PJ, Shah AM. Paracrine coronary endothelial control of left ventricular function in humans. Circulation. 92:1995;2119-2126.
3. Arrowood JA, Goudreau E, Minisi AJ, Davis AB, Mohanty PK. Evidence against reinnervation of cardiac vagal afferents after human orthotopic cardiac transplantation. Circulation. 92:1995;402-408.
4. Drexler H, Fischell TA, Pinto FJ, et al. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients Relation to vessel wall morphology . Circulation. 89:1994;1615-1623.
5. Lewis NP, Tsao PS, Rickenbacher PR, et al. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation. 93:1996;720-729.
6. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide physiology, pathophysiology, and pharmacology . Physiol Rev. 43:1991;109-142.
7. Xie Q, Cho HJ, Calaycay J, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 256:1992;225-228.
8. Simmons WW, Park MY, Cunningham JM, Kelly RA, Smith TW. Regulation of inducible nitric oxide synthase activity by the co-induction of cationic amino acid transporters in cardiac myocytes [abstract]. Circulation. 92:(Suppl I):1995;I-5.
9. de Belder AJ, Radomski MW, Why HJ, Richardson PJ, Martin JF. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. Br Heart J. 74:1995;426-430.
10. Haywood GA, Tsao PT, von der Leyen HE, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 93:1996;1087-1094.
11. Koifman B, Wollman Y, Bogomolny N, et al. Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure. J Am Coll Cardiol. 26:1995;1251-1256.
12. Chin-Dusting JPF, Kaye DM, Lefkovits J, Wong J, Bergin P, Jennings GL. Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure. J Am Coll Cardiol. 27:1996;1207-1213.
13. Rector TS, Bank AJ, Mullen KA, et al. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation. 93:1996;2135-2141.
14. Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient coronary arteriographic findings . J Am Coll Cardiol. 12:1988;334-340.
15. Drexler H, Zeiher A, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet. 338:1991;1546-1550.
16. Hirooka Y, Egashira K, Imaizumi T, et al. Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans. J Am Coll Cardiol. 24:1994;948-955.
17. Bartunek J, Shah AM, Vanderheyden M, Paulus WJ. Dobutamine enhances cardiodepressant effects of receptor-mediated coronary endothelial stimulation. Circulation. 95:1997;90-96.
18. Geller DA, Lowenstein CJ, Shapiro RA, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA. 90:1993;3491-3495.
19. Fifer MA, Grossman W. Measurement of ventricular volumes, ejection fraction, mass and wall stress. Grossman W, Baim DS. Cardiac Catheterization, Angiography, and Intervention. 4th ed. 1991;300-318 Lea & Febiger, Philadelphia.
20. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
21. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation. 87:1993;1475-1481.
22. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 90:1992;1248-1253.
23. Hirooka Y, Imaizumi T, Tagawa T, et al. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation. 90:1994;658-668.
24. Smith JA, Shah AM, Lewis MJ. Factors released from endocardium of the ferret and pig modulate myocardial contraction. J Physiol (Lond). 439:1991;1-14.
25. Grocott-Mason R, Anning P, Evans H, Lewis MJ, Shah AM. Modulation of left ventricular relaxation in the isolated ejecting heart by endogenous nitric oxide. Am J Physiol. 267:1994;H1804-H1813.
26. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization beyond nitric oxide and cyclic GMP . Circulation. 92:1995;3337-3349.
27. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients. J Am Coll Cardiol. 23:1994;844-850.
28. Mohan P, Brutsaert DL, Sys SU. Myocardial performance is modulated by interaction of cardiac-endothelium derived nitric oxide and prostaglandins. Cardiovasc Res. 29:1995;637-640.
29. Bode-Boger SM, Boger RH, Alfke H, et al. L-Arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia A randomised, controlled study . Circulation. 93:1996;85-90.
30. Mehta S, Stewart DJ, Langleben D, Levy RD. Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension. Circulation. 92:1995;1539-1545.
31. Finkel MS, Odis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:1992;387-389.
32. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol. 263:1992;H1963-H1966.
33. Balligand JL, Ungureanu D, Kelly RA, et al. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 91:1993;2314-2319.
34. Evans HG, Lewis MJ, Shah AM. Interleukin-1β modulates myocardial contraction via dexamethasone-sensitive production of nitric oxide. Cardiovasc Res. 27:1993;1486-1490.
35. i and cell contraction in cultured chick ventricular myocytes. Circ Res. 75:1994;285-295.
36. Ungureanu-Longrois D, Balligand JL, Simmons WW, et al. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to β-adrenergic agonists. Circ Res. 77:1995;494-502.
37. Hare JM, Keaney JF Jr, Balligand JL, Loscalzo J, Smith TW, Colucci WS. Role of nitric oxide in parasympathetic modulation of β-adrenergic myocardial contractility in normal dogs. J Clin Invest. 95:1995;360-366.
38. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 92:1995;2198-2203.
39. Little WC, Park RC, Freeman GL. Effects of regional ischemia and ventricular pacing on LV dP/dt max-end-diastolic volume relation. Am J Physiol. 252:1987;H933-H940.
40. Kass DA, Maughan WL. From Emax to pressure-volume relations a broader view . Circulation. 77:1988;1203-1212.